SLONIN JONATHAN sold PCRX
March 17, 2026 · Form 4 insider transaction
SLONIN JONATHAN sold 3,261 shares of Pacira BioSciences, Inc. at $22.82 per share, a transaction worth $74.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,261
Price
$22.82
Total value
$74.4K
InsiderSLONIN JONATHAN
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 17, 2026
Filing dateMarch 19, 2026
Shares owned after223,640
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on August 12, 2025.